Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Non Small Cell Lung Cancer × Drug Therapy × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 18 Neoplasm Metastasis 8 Lung Neoplasms 7 Colorectal Neoplasms 7 Breast Neoplasms 7 Esophageal Squamous Cell Carcinoma 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Small Cell Lung Carcinoma 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Rectal Neoplasms 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Cholangiocarcinoma 2

Interventions

pembrolizumab 1 osimertinib 1 durvalumab 1 AZD 6244 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡